Want to track CATX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Perspective Therapeutics Inc. (CATX) Statistics
Valuation metrics
Market Cap 238.7M
Enterprise value 181.24M
Trailing P/E (ttm) -0.11
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 373.75
Price/Book (mrq) 0.01
Enterprise Value/Revenue 293.26
Enterprise Value/EBITDA -1.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 851.08K
Average volume (90 days) 1.72M
Price summary
52-Week low 1.96
52-Week high 6.16
Beta -
50-Day moving average 3.03
200-Day moving average 4.06
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 17 Jun 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -179.83%
Operating margin -194.2%
Operational effectiveness
Return on assets -0.27%
Return on equity -0.42%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.6
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -107.27
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 261.5
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 8.75%
Book value per share (mrq) 335.35
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
